Article
DDAH1 and DDAH2 drive vasculogenic mimicry and more aggressive phenotypes in triple negative breast cancer cells.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Aug 2026
Meyers Jai, Weerakoon Lashika, Ragavan Vinitha, Jarzebska Natalia, Rodionov Roman N, Mangoni Arduino A, Hulin Julie-Ann, Tommasi Sara
Abstract excerpt
The overexpression of dimethylarginine dimethylaminohydrolase 1 (DDAH1) and 2 (DDAH2) has been associated with several types of cancer. Specifically, DDAH1 has been shown to play a critical role in the establishment of a vascular network by tumour cells, vasculogenic mimicry (VM), in triple negative breast cancer (TNBC). In turn, VM favours TNBC progression and is associated with poor patient prognosis. DDAH1 is...
Topics
Join the communities discussing this publication.
